Voluntary and Business Update Announcement Signing Collaboration Agreements for Class 1 Innovative Biologic Recombinant Humanized Anti-tetanus Toxin Monoclonal Antibody Vecantoxatug Injection and Recombinant Fully Human Bispecific Antibody Against Rabies Virus Silevimig Injection